home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Novel approach to gene therapy for beta-thalassemia

  May, 4 1998 14:41
your information resource in human molecular genetics
Gene therapy is one the most promising treatments for genetic disorders. It is usually understood as either the

replacement of a defective gene with the correct one or the expression of a transgene whose product supplants its defective counterpart.

In several forms of beta-thalassemia, mutations in the second intron of the beta-globin gene create aberrant 5' splice sites and activate a common cryptic 3' splice site upstream. As a result, the thalassemic beta-globin pre-mRNAs are spliced almost exclusively via the aberrant splice sites leading to a deficiency of correctly spliced beta-globin mRNA protein. Gorman et al. have designed a series of vectors that express modified U7 snRNAs containing antisense sequences to aberrant splice sites in the thalassemic pre-mRNA. The antisense sequences are able to block the aberrant splice sites and restore the correct splicing pattern by forcing the splicing machinery to reselect the existing correct splice sites. Transient expression of modified U7 snRNAs in a HeLa cell line stably expressing the anomalous beta-globin gene significantly restored correct splicing in a sequence-specific and dose-dependent manner. This novel approach provides a

potential alternative to gene replacement therapies. (SOURCE: Proceedings of the National Academy of Sciences USA)

REFERENCE: Gorman L, Suter D, Emerick V, Schumperli D, Kole R.1998.Stable alteration of pre-mRNA splicing patterns by

modified U7 small nuclear RNAs. Proc. Natl. Acad. Sci. U.S.A. 95(9):4929-4934

Message posted by: Frank S. Zollmann

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.